Patterns of pulmonary complications associated with sirolimus.
about
Ten things you should know about protein kinases: IUPHAR Review 14Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenibIFN-γ stimulates autophagy-mediated clearance of Burkholderia cenocepacia in human cystic fibrosis macrophagesHistological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.Emerging drugs in lung transplantation.Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell inductionElastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.Proliferation signal inhibitor toxicities after thoracic transplantation.Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature.Sirolimus induced granulomatous interstitial pneumonitis.Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent.Proteostasis in cardiac health and disease.
P2860
Q26849417-EF7D67DA-844D-462B-BB42-3F0743CCC5FFQ28765488-3F82F26C-E747-4768-AC77-82093B977498Q33568014-25ADED29-30AC-4429-B372-0F4E9E673852Q35935114-712C6FF1-4465-4792-A209-2EDE90878267Q36758582-1400909C-31AA-48EA-BE7E-BA822658AA5BQ36814620-158C77AD-D487-4F0F-BBCE-4B393AC53E7DQ37227448-D6D688E0-9ADC-4CC9-96AA-31822ABBA422Q37495852-1339AEA5-DA45-4636-BCA0-3CC9BA016B7DQ37508003-45898A1A-3FBA-4273-AD8D-3BD5204073AFQ37701147-3ABDA5FF-756D-4D1B-A877-CD4DC9185961Q38044748-E0B51574-3596-4967-8A65-B0E7F8F98DB6Q38314899-58D6F200-56EE-42DB-B6F2-1CA316CBDE7BQ38510349-BAE33959-9A9B-4302-93B4-0F2E8687B906Q38961196-7B978448-7815-4621-8819-5AC7498D8E17Q39404378-9DCA55DB-21DF-4511-865A-1469A33D34A2
P2860
Patterns of pulmonary complications associated with sirolimus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Patterns of pulmonary complications associated with sirolimus.
@ast
Patterns of pulmonary complications associated with sirolimus.
@en
Patterns of pulmonary complications associated with sirolimus.
@nl
type
label
Patterns of pulmonary complications associated with sirolimus.
@ast
Patterns of pulmonary complications associated with sirolimus.
@en
Patterns of pulmonary complications associated with sirolimus.
@nl
prefLabel
Patterns of pulmonary complications associated with sirolimus.
@ast
Patterns of pulmonary complications associated with sirolimus.
@en
Patterns of pulmonary complications associated with sirolimus.
@nl
P2093
P2860
P356
P1433
P1476
Patterns of pulmonary complications associated with sirolimus.
@en
P2093
Jurg Steiger
Lukas Bubendorf
Michael Dickenmann
Michael Tamm
Prashant N Chhajed
P2860
P304
P356
10.1159/000087945
P50
P577
2005-08-25T00:00:00Z